NRAS and leptomeningeal melanoma: Furthermore, some additional molecular alterations, such as SF3B1, EIF1AX, and BAP1 mutations, confer a significant aggressive course in meningeal melanoma, while both primary diffuse leptomeningeal melanocytosis or melanomatosis are often NRAS mutated and rarely BRAF mutated.